Neuroleptic malignant syndrome in a COVID-19 patient

MeSH terms

• Acute Kidney Injury / etiology
• Acute Kidney Injury / therapy
• Antipsychotic Agents / adverse effects*
• Betacoronavirus
• Bromocriptine / therapeutic use
• C-Reactive Protein / immunology
• COVID-19
• Coronavirus Infections / complications*
• Coronavirus Infections / immunology
• Coronavirus Infections / physiopathology
• Coronavirus Infections / therapy
• Dantrolene / therapeutic use
• Dopamine Agonists / therapeutic use
• Enzyme Inhibitors / therapeutic use
• Haloperidol / adverse effects
• Haloperidol / analogs & derivatives*
• Humans
• Hydroxychloroquine / therapeutic use
• Intensive Care Units
• Leukocytosis
• Lymphopenia
• Male
• Middle Aged
• Muscle Relaxants, Central / therapeutic use
• Neuroleptic Malignant Syndrome / etiology*
• Neuroleptic Malignant Syndrome / physiopathology
• Neuroleptic Malignant Syndrome / therapy
• Pandemics
• Pneumonia, Viral / complications*
• Pneumonia, Viral / immunology
• Pneumonia, Viral / physiopathology
• Pneumonia, Viral / therapy
• Renal Dialysis
• Respiration, Artificial
• Rhabdomyolysis / etiology
• Rhabdomyolysis / therapy
• SARS-CoV-2
• Schizophrenia / complications
• Schizophrenia / drug therapy*